Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selective Laser Trabeculoplasty Versus Latanoprost as First Line Treatments for Primary Open-angle Glaucoma and Ocular Hypertension: A Comparative Analysis

NCT07310719 is registered in ClinicalTrials.gov with Lagos State Health Service Commission as lead sponsor.

NCT NCT07310719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07310719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selective Laser Trabeculoplasty Versus Latanoprost as First Line Treatments for Primary Open-angle Glaucoma and Ocular Hypertension: A Comparative Analysis
Lead sponsor
Lagos State Health Service Commission
Phase
Not applicable
Overall status
Recruiting
Start date
October 15, 2025
Completion date
November 30, 2026
Enrollment
138 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary open angle glaucoma or ocular hypertension